Clonal hematopoiesis: Molecular basis and clinical relevance

Area of Science:

• Genomics
• Hematology
• Oncology

Background:

• Clonal hematopoiesis of indeterminate potential (CHIP) involves common clonal expansion in older adults.
• CHIP is linked to increased risks of hematological malignancies and cardiovascular diseases, impacting survival.
• Frequently mutated genes in CHIP are involved in epigenetic regulation, signaling, DNA repair, and RNA splicing.

Purpose of the Study:

• To explore the pleiotropic effects of CHIP-associated genetic mutations on hematopoietic stem cell functions.
• To investigate the clinical relevance of CHIP in managing hematological malignancies.
• To elucidate clonal evolution in CHIP for developing preventive strategies and novel treatments.

Main Methods:

• Genomic studies identifying recurrent somatic mutations.
• Analysis of gene mutations in epigenetic modification, cell signaling, DNA damage response, and RNA splicing.
• Clinical studies assessing CHIP relevance in hematological malignancy management.

Main Results:

• CHIP is prevalent in older individuals without hematological malignancies.
• CHIP mutations affect HSC functions, gene regulation, DNA repair, and stress resistance.
• CHIP has demonstrated clinical relevance in hematological malignancy contexts.

Conclusions:

• Understanding CHIP and clonal evolution is crucial for developing new preventive measures and treatments.
• CHIP represents a significant risk factor for hematological malignancies and cardiovascular diseases.
• Further research into CHIP mechanisms can guide therapeutic strategies for related diseases.